Purpose. The use of MRI contrast agents outside their labeled indications i
s routine in radiology. However, physicians feel frequently at unease. It i
s the aim of this paper to introduce the medical, juridicial and billing re
levant issues in order to improve the knowledge on this topic.
Methods. The basis for off-label use is the physician's prerogative, which
finds its basis in the "declaration of Helsinki".
Results. Off-label use is allowed under special conditions and might be eve
n the medical state of the art.
Conclusion. The necessity for off-label use will continue to increase for M
R-contrast agents, as clinical trials for registration purpose are quite co
stly and manufactures continuously will concentrate on the essential indica
tions.